While HPV is the most common sexually transmitted infection globally, understanding exactly which specific viral strain you carry is absolutely vital for highly accurate clinical risk stratification.
High-risk HPV strains (most notably HPV-16 and HPV-18) are directly responsible for the vast majority of anal dysplasia cases and subsequent carcinomas.
Our specialized Anal HPV Testing protocols isolate the exact viral DNA present in the mucosal lining of the anal canal, definitively identifying the specific genotype of the virus.
This highly sensitive, advanced molecular diagnostic provides Dr. Farabi with the exact genomic data required to determine your true clinical risk profile.
Based directly on these highly specific laboratory results, we establish a personalized, strictly evidence-based clinical surveillance timeline, ensuring that any potential microscopic cellular changes are monitored aggressively and addressed with the utmost clinical precision to protect your long-term health.
